Share on LinkedInShare on LinkedIn

ARTICLE · 23 JULY 2019

New Human Genetic Resources Regulations In China

Hogan Lovells
Explore more from Hogan Lovells

On 28 May 2019, the People's Republic of China State Council promulgated the People's Republic of China Human Genetic Resources

ChinaGovernment, Public Sector
Roy G. Zou
Roy G. Zou
Andrew McGinty
Andrew McGinty
Jessie J. Xie
Jessie J. Xie
Lu Zhou
Lu Zhou

China's New Regulations on the Administration of Chinese Human Genetic Resources: will 'China first' prevail over 'science first' in the Biotechnology Era?

On 28 May 2019, the People's Republic of China State Council promulgated the People's Republic of China Human Genetic Resources Administrative Regulations, which took effect on 1 July 2019 ("2019 Human Genetic Resource Regulations", our unofficial inhouse translation is available on request to existing or potential clients by emailing Karen Yang [email protected]) to replace the interim measures issued two decades ago (i.e. the Human Genetic Resources Administration Interim Measure ("Former Human Genetic Resource Regulations"). In broad terms, the 2019 Human Genetic Resources Regulations regulate the collection, preservation, utilization, and provision to third parties including the export of Chinese human genetic resources, as well as spelling out the punishments that may accompany violations of the

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

In-Depth Analysis Of State Council Order No. 841: Who Will Be Affected By The New Exit And Entry Administration Rules?

China's new exit and entry regulations introduce significant changes affecting technical personnel, individuals with cross-border assets, public officials, and intermediary service providers. The provisions strengthen authenticity reviews, connect technology export controls with travel restrictions, and establish a comprehensive framework for managing cross-border movement while balancing national security with legitimate international activities.
ChinaGovernment, Public Sector
Han Kun Law Offices
Han Kun Law Offices
Article

Bipartisan Senate Bill Would Prevent “Offshoring Biotech Industry To Communist China”

Senators Pete Ricketts and Elissa Slotkin have introduced bipartisan legislation that would subject American investments in adversary biotechnology to federal review requirements. The Biotech Investment National Security Act would amend the COINS Act to include pharmaceutical and biological product development in the list of sectors requiring Treasury Department screening for outbound investments to countries of concern, particularly China.
ChinaGovernment, Public Sector
Bergeson & Campbell
Bergeson & Campbell
Article

China Links Export Controls To Exit Bans: What State Council Order No. 841 Means For Multinational Companies

China's new immigration regulation introduces a significant provision allowing exit bans on Chinese citizens who violate export control or technology transfer rules that may endanger national, industrial, or technological security. This development creates potential complications for multinational companies operating in technology-intensive industries, as Chinese employees, engineers, researchers, or executives could be barred from departing China without prior notice, affecting cross-border mobility, joint
ChinaGovernment, Public Sector
Greenberg Traurig
Greenberg Traurig